Research output per year
Research output per year
Personal profile
Research interests
Onderzoeksbelangen
Fingerprint
Dive into the research topics where Jasper van der Lugt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas
Vazaios, K., Tallon-Cobos, A. C., van Oosterhout, L. P. J., Waranecki, P., Cornel, A. M., Dautzenberg, N. M. M., van Hoesel, M., Forbes, C., Nierkens, S., Kemp, V., Hoeben, R. C., van der Lugt, J., Calkoen, F. G. & Hulleman, E., 18 Jun 2026, In: Molecular Therapy Oncology. 34, 2, 201191.Research output: Contribution to journal › Article › peer-review
Open Access -
CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models
Tallon-Cobos, A. C., Vazaios, K., Waranecki, P., van Hoesel, M., Cornel, A., Schwalm, B., Mack, N., de Boed, E., van der Lugt, J., Nierkens, S., Kool, M., Hoving, E. W., Metselaar, D. S. & Hulleman, E., 16 Jan 2026, In: The Journal of clinical investigation. 136, 2Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies
Federico, A., Schmitt-Hoffner, F., Fonseca, A., Geisemeyer, N., Bruckner, K., Mauermann, M., Sill, M., Stichel, D., Sturm, D., Schüller, U., Tauziede-Espariat, A., Varlet, P., Capper, D., Abdullaev, Z., Schrimpf, D., Selt, F., Williamson, L., Donson, A. M., Antonelli, M. & Miele, E. & 31 others, , Apr 2026, In: Neuro-Oncology. 28, 4, p. 1005-1019 15 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325]
Langenberg, K. P. S., Meister, M. T., Bakhuizen, J. J., Boer, J. M., van Eijkelenburg, N. K. A., Hulleman, E., Ilan, U., Looze, E. J., Dierselhuis, M. P., Lugt, J. V. D., Breunis, W., Schild, L. G., Ober, K., van Hooff, S. R., Scheijde-Vermeulen, M. A., Hiemcke-Jiwa, L. S., Flucke, U. E., Kranendonk, M. E. G., Wesseling, P. & Sonneveld, E. & 34 others, , 15 May 2025, In: European Journal of Cancer. 221, 115423.Research output: Contribution to journal › Comment/debate
Open Access1 Citation (Scopus) -
Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?
Kranendonk, M. E. G., Hoogendijk, R., Lammers, J. A. S., Van Der Lugt, J., Tolboom, N., Van Mastrigt, E., De Boed, E., Van Den Broek, T. J. M., Kester, L. A., Van Vuurden, D. G., Tops, B. B. J., Hoving, E. W., Wesseling, P. & Plasschaert, S. L. A., 1 Jul 2025, In: Neuro-Oncology. 27, 7, p. 1864-1877 14 p.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus)